Clay, NY, United States of America

Jeng S Lin

This inventor holds 4 USPTO granted patents. Top assignee: Bristol-Myers Company. Active years: 1980-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeng S Lin. Retrieved from https://idiyas.com/inventor/jeng-s-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1980-1984

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Jeng S Lin

Introduction

Jeng S Lin is a notable inventor based in Clay, NY (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of four patents, showcasing his innovative approach to antibiotic development.

Latest Patents

Among his latest patents is the "Preparation of 1-N-ω-amino-α-hydroxyalkanoyl!kanamycin." This patent describes an improved process for preparing kanamycins by acylating a polysilylated kanamycin in a substantially anhydrous organic solvent with an acylating derivative of an ω-amino-α-hydroxyalkanoic acid. Another significant patent is the "Preparation of 1-N-[ω-amino-α-hydroxyalkanoyl]aminoglycoside." This invention outlines an enhanced method for producing aminoglycoside antibiotics through a similar acylation process.

Career Highlights

Jeng S Lin is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts in the pharmaceutical industry. His work has significantly impacted the field of antibiotic production, leading to more effective treatments.

Collaborations

Throughout his career, Jeng has collaborated with esteemed colleagues such as Martin J Cron and John G Keil. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Jeng S Lin's contributions to antibiotic development through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the field and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…